Skip to main content
FinSpry Logo
FinSpry
CSTL logo
CSTL
(NASDAQ)
Castle Biosciences, Inc.
$21.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Castle Biosciences (CSTL) Stock Price & Financial Analysis

Castle Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$20.53 - $21.29
52-Week High$44.28
52-Week Low$14.59
Open$21.07
Volume215.21K
Average Volume (3M)457.27K
Market Cap611.02M
Shares Outstanding28.99M
Price to Sales (P/S)1.78
Price to Book (P/B)1.30
EV/EBITDA95.89
Revenue (TTM)344.23M
Net Income (TTM)-33.49M
Free Cash Flow (TTM)28.33M
EPS (TTM)$-1.15
Profit Margin-9.73%
Operating Margin-12.44%
Return on Equity (ROE)-7.11%
Debt to Equity0.08
50-Day MA$22.35
200-Day MA$28.77
52-Week Change13.94%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Castle Biosciences

What is the current stock price for CSTL?

As of the latest trading session, CSTL stock trades at $21.01. The 52-week range is $14.59–$44.28, with a day range of $20.53–$21.29.

What is the P/E ratio for CSTL?

The P/E ratio (Price-to-Earnings) for CSTL is shown in the Key Statistics section. This valuation metric helps compare Castle Biosciences, Inc. to industry peers.

Does CSTL pay dividends?

Castle Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSTL?

Based on 1 analyst, the consensus for CSTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CSTL?

Castle Biosciences's market capitalization is $609.0M, classifying it as a small-cap company. Castle Biosciences operates in the Healthcare sector within the Diagnostics & Research industry.